Aspen Aerogels (ASPN) Cost of Revenue (2013 - 2026)

Aspen Aerogels has reported Cost of Revenue for 14 years, with the latest figure at $6.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 88.07% year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $72.1 million (down 13.37% YoY), and the FY2025 full-year result was $28.2 million, down 20.96% from the prior year.
• Cost of Revenue for Q1 2026 stood at $6.7 million, up from $6.3 million in the prior quarter.
• The five-year high for Cost of Revenue was $154.4 million in Q4 2022, with the low at $6.3 million in Q4 2025.
• Historically, Cost of Revenue has averaged $34.2 million across 5 years, with a median of $9.5 million in 2024.
• Annual changes were most pronounced in 2022 — Cost of Revenue surged 1213.09% — and 2026, when it slumped 88.07%.
• Aspen Aerogels' Cost of Revenue stood at $154.4 million in 2022, then sank by 64.65% to $54.6 million in 2023, then slumped by 84.35% to $8.5 million in 2024, then slipped by 26.11% to $6.3 million in 2025, then increased by 5.59% to $6.7 million in 2026.
• The last three Cost of Revenue figures came in at $6.7 million (Q1 2026), $6.3 million (Q4 2025), and $52.2 million (Q3 2025), per Business Quant data.